Portfolio company
StimCardio
United States · £23.7m raised
Raised
£23.7m
Latest stage
Series A
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops non-invasive wearable neuromodulation devices for patients with atrial fibrillation to reduce heart arrhythmia recurrence following medical procedures.
SourceFunding history · 1
Similar companies
VentriJect
This company develops a sensor and algorithm to estimate cardiorespiratory fitness through chest vibrations for healthcare professionals, researchers and fitness centres.
Maxwellbiomedical
This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.
BEATLAB
This company develops a decision support tool using AI and pulse-wave measurements to provide cardiovascular analysis and detect arterial stenosis for healthcare providers.
Corify Care
Corify Care develops a non-invasive cardiac mapping system for clinicians to diagnose and plan treatments for patients with heart arrhythmias.
Vektor Medical
The company develops AI-based, non-invasive arrhythmia analysis software for electrophysiologists to locate cardiac arrhythmia sources using standard electrocardiograms.
Levron
This company develops a cardio-respiratory physiological assist device that synchronises heart rhythm with respiratory dynamics for patients with chronic heart failure.
XTrodes
This company develops wearable wireless skin patches for electrophysiological monitoring, providing medical-grade data for healthcare providers, researchers, and patients in natural environments.
Stimvia
Stimvia manufactures non-invasive neuromodulation medical devices for patients with overactive bladder and other chronic neurological disorders.
